Obstetrx: Funding, Investors & Team (Oct 2026)
Obstetrx creates a uterine tamponade device to eliminate maternal death and disability from postpartum hemorrhage. In 2014, RevMedx, Inc. developed the XSTAT® hemorrhage-control device in concert with the US military to stop severe bleeding from non-compressible wounds suffered on the battlefield. They soon realized that this type of traumatic bleeding, which XSTAT has been proven successful in treating, is highly analogous to postpartum hemorrhage. Inspired to address this global issue in women’s health, the team quickly got to work adapting the combat medicine technology for an obstetric application. RevMedx partnered with a team from Oregon Health & Science University, who received a Saving Lives at Birth Grand Challenge grant to conduct early-stage research and development. This work culminated in a pre-clinical proof-of-concept study. With the inception of Obstetrx, Inc, a pilot clinical trial was performed in Zambia in 2019. Today, Obstetrx is a privately-held company based in Wilsonville, OR. We are currently working toward regulatory clearance and commercialization of our novel uterine tamponade device in the US and across the globe.
Obstetrx has raised $1.1M across 1 funding round on record, the most recent an Angel of $1.1M announced in Aug 2021.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Obstetrx Company Profile and Key Stats
Latest funding round on record: Aug 2021.
Obstetrx Funding Rounds
Obstetrx Founders and Leadership Team
No contact details are on record for this team yet.
Obstetrx Funding Compared to Other Health Care Startups
Obstetrx's latest round of $1.1M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Obstetrx in Health Care and Wilsonville
Companies Similar to Obstetrx
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Obstetrx Funding FAQs
What does Obstetrx do?
Obstetrx creates a uterine tamponade device to eliminate maternal death and disability from postpartum hemorrhage. In 2014, RevMedx, Inc. developed the XSTAT® hemorrhage-control device in concert with the US military to stop severe bleeding from non-compressible wounds suffered on the battlefield. They soon realized that this type of traumatic bleeding, which XSTAT has been proven successful in treating, is highly analogous to postpartum hemorrhage. Inspired to address this global issue in women’s health, the team quickly got to work adapting the combat medicine technology for an obstetric application. RevMedx partnered with a team from Oregon Health & Science University, who received a Saving Lives at Birth Grand Challenge grant to conduct early-stage research and development. This work culminated in a pre-clinical proof-of-concept study. With the inception of Obstetrx, Inc, a pilot clinical trial was performed in Zambia in 2019. Today, Obstetrx is a privately-held company based in Wilsonville, OR. We are currently working toward regulatory clearance and commercialization of our novel uterine tamponade device in the US and across the globe.
How much funding has Obstetrx raised?
Obstetrx has raised $1.1M across 1 round on record. The most recent is an Angel of $1.1M announced in Aug 2021.
When did Obstetrx last raise funding?
Obstetrx's most recent funding round on record is an Angel of $1.1M, announced in Aug 2021.
Who is the CEO of Obstetrx?
Andrew Barofsky is listed as CEO at Obstetrx.
Where is Obstetrx headquartered?
Obstetrx is based in Wilsonville, Oregon, United States.
How many employees does Obstetrx have?
Obstetrx is in the 1-10 employee band.
How does Obstetrx's funding compare to other Health Care startups?
Obstetrx's latest round of $1.1M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Obstetrx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Obstetrx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.